The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 09, 2023
Filed:
May. 14, 2021
Applicant:
Theravance Biopharma R&d Ip, Llc, South San Francisco, CA (US);
Inventors:
Melissa Fleury, Brisbane, CA (US);
Adam D. Hughes, Half Moon Bay, CA (US);
Anne-Marie Beausoleil, Redwood City, CA (US);
Erik Fenster, San Bruno, CA (US);
Venkat R. Thalladi, Foster City, CA (US);
Miroslav Rapta, San Carlos, CA (US);
Assignee:
THERAVANCE BIOPHARMA R&D IP, LLC, South San Francisco, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/421 (2006.01); A61K 9/48 (2006.01); A61K 47/12 (2006.01); C07D 263/34 (2006.01); C30B 7/14 (2006.01); C30B 29/54 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/421 (2013.01); A61K 9/4816 (2013.01); A61K 9/4825 (2013.01); A61K 45/06 (2013.01); A61K 47/12 (2013.01); C07D 263/34 (2013.01); C30B 7/14 (2013.01); C30B 29/54 (2013.01); C07B 2200/13 (2013.01);
Abstract
In one aspect, the invention relates to a compound of the structure: or a pharmaceutically acceptable salt thereof, and a crystalline form of this compound, having neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising this compound; methods of using this compound; and processes for preparing this compound.